These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28442470)

  • 1. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
    Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
    J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
    Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
    Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans cell histiocytosis: 23 years' paediatric experience highlights severe long-term sequelae.
    Martin A; Macmillan S; Murphy D; Carachi R
    Scott Med J; 2014 Aug; 59(3):149-57. PubMed ID: 24996784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
    Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
    Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
    Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
    Minkov M
    Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine features of Langerhans cell histiocytosis in paediatric patients: A 30-year review.
    Alexander A; Zacharin M
    J Paediatr Child Health; 2024 Jan; 60(1):24-27. PubMed ID: 38031464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.
    Vaiani E; Felizzia G; Lubieniecki F; Braier J; Belgorosky A
    Horm Res Paediatr; 2021; 94(1-2):9-17. PubMed ID: 34167121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.
    Mittheisz E; Seidl R; Prayer D; Waldenmair M; Neophytou B; Pötschger U; Minkov M; Steiner M; Prosch H; Wnorowski M; Gadner H; Grois N
    Pediatr Blood Cancer; 2007 Jan; 48(1):50-6. PubMed ID: 16470521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis.
    Maghnie M; Bossi G; Klersy C; Cosi G; Genovese E; Aricò M
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3089-94. PubMed ID: 9745408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
    Kaltsas GA; Powles TB; Evanson J; Plowman PN; Drinkwater JE; Jenkins PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1370-6. PubMed ID: 10770168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
    Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
    Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre.
    Bernstrand C; Sandstedt B; Ahström L; Henter JI
    Acta Paediatr; 2005 Aug; 94(8):1073-84. PubMed ID: 16188852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
    Modest MC; Garcia JJ; Arndt CS; Carlson ML
    Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors.
    Lau LM; Stuurman K; Weitzman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):607-12. PubMed ID: 17973322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
    Imashuku S; Shioda Y; Kobayashi R; Hosoi G; Fujino H; Seto S; Wakita H; Oka A; Okazaki N; Fujita N; Minato T; Koike K; Tsunematsu Y; Morimoto A;
    Haematologica; 2008 Apr; 93(4):615-8. PubMed ID: 18287136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hungarian experience with Langerhans cell histiocytosis in childhood.
    Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
    Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.